| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFM861 |
| P698 | PubMed publication ID | 18334529 |
| P2093 | author name string | Ayinuer Adijiang | |
| Toshimitsu Niwa | |||
| Fuyuhiko Nishijima | |||
| Sumie Goto | |||
| Satsuki Uramoto | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1892-1901 | |
| P577 | publication date | 2008-03-11 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats | |
| P478 | volume | 23 |
| Q84804629 | Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats |
| Q34641464 | An update on uremic toxins |
| Q43461034 | Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease |
| Q60917395 | Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease |
| Q34828638 | Association of indoxyl sulfate with heart failure among patients on hemodialysis |
| Q26784008 | Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes |
| Q41808884 | Classification of Five Uremic Solutes according to Their Effects on Renal Tubular Cells. |
| Q89451315 | Crosstalk between the nervous system and the kidney |
| Q35030559 | Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins |
| Q46847494 | Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin |
| Q37641160 | Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access |
| Q58749760 | Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120 |
| Q41497001 | Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease |
| Q37783421 | Indoxyl Sulfate Is a Nephro-Vascular Toxin |
| Q92800661 | Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance |
| Q39125093 | Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. |
| Q35056721 | Indoxyl sulfate promotes apoptosis in cultured osteoblast cells |
| Q99730865 | Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS/NF-κB signaling |
| Q34621513 | Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB. |
| Q54657758 | Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats |
| Q35364712 | Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells |
| Q37409977 | Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats |
| Q58768679 | Lower risk of musculoskeletal pain among patients with end-stage renal disease treated by hemodialysis: A frequency-matched retrospective cohort study |
| Q37883149 | Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon |
| Q42876598 | Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry |
| Q90703732 | Microbiota issue in CKD: how promising are gut-targeted approaches? |
| Q41688602 | Microvesicles Derived from Indoxyl Sulfate Treated Endothelial Cells Induce Endothelial Progenitor Cells Dysfunction. |
| Q46128928 | Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. |
| Q92815678 | Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate |
| Q46099829 | Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy |
| Q50084720 | Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and cats. |
| Q49723746 | Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes |
| Q35901218 | Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis |
| Q35503190 | Protein-bound solute removal during extended multipass versus standard hemodialysis |
| Q38190366 | Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients |
| Q52680882 | Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. |
| Q41514235 | Role of Gut-derived Uremic Toxins on Oxidative Stress and Inflammation in Patients with Chronic Kidney Disease |
| Q55254641 | Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction. |
| Q36583339 | Searching for uremic toxins |
| Q59677148 | Senescent Microvesicles: A Novel Advance in Molecular Mechanisms of Atherosclerotic Calcification |
| Q37378435 | Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients |
| Q55515015 | The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. |
| Q65002701 | The Role of the Microbiota in the Diabetic Peripheral Artery Disease. |
| Q26795563 | The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective |
| Q34103477 | The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review |
| Q57296687 | Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions |
| Q37641040 | Uremic toxins originating from colonic microbial metabolism |
| Q33560454 | p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients |
Search more.